[HTML][HTML] Resveratrol (RV): A pharmacological review and call for further research

LX Zhang, CX Li, MU Kakar, MS Khan, PF Wu… - Biomedicine & …, 2021 - Elsevier
Resveratrol (RV) is a well-known polyphenolic compound in various plants, including grape,
peanut, and berry fruits, which is quite famous for its association with several health benefits …

[HTML][HTML] Neuroprotective mechanisms of resveratrol in Alzheimer's disease: role of SIRT1

BAQ Gomes, JPB Silva, CFR Romeiro… - … medicine and cellular …, 2018 - hindawi.com
Alzheimer's disease (AD) is a progressive and neurodegenerative disorder of the cortex and
hippocampus, which eventually leads to cognitive impairment. Although the etiology of AD …

[HTML][HTML] Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches

I Morales, L Guzmán-Martínez… - Frontiers in cellular …, 2014 - frontiersin.org
Alzheimer disease (AD) is the most common cause of dementia in people over 60 years old.
The molecular and cellular alterations that trigger this disease are still diffuse, one of the …

Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer's disease from bench to bedside

F Islam, MH Nafady, MR Islam, S Saha, S Rashid… - Molecular …, 2022 - Springer
Alzheimer's disease (AD) is the most common cause of dementia and cognitive impairment;
yet, there is currently no treatment. A buildup of Aβ, tau protein phosphorylation, oxidative …

Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases

V Ivasiv, C Albertini, AE Gonçalves… - Current Topics in …, 2019 - ingentaconnect.com
Molecular hybridization is a well-exploited medicinal chemistry strategy that aims to combine
two molecules (or parts of them) in a new, single chemical entity. Recently, it has been …

Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease

N Guzior, A Wieckowska, D Panek… - Current medicinal …, 2015 - ingentaconnect.com
Alzheimer's disease (AD) is a complex and progressive neurodegenerative disorder. The
available therapy is limited to the symptomatic treatment and its efficacy remains …

[HTML][HTML] Neuroprotective effects of resveratrol in Alzheimer disease pathology

SD Rege, T Geetha, GD Griffin, TL Broderick… - Frontiers in aging …, 2014 - frontiersin.org
Alzheimer's disease is a chronic neurodegenerative disorder characterized by a progressive
loss of cognitive and behavioral abilities. Extracellular senile plaques and intracellular …

Resveratrol and Alzheimer's disease: mechanistic insights

T Ahmed, S Javed, S Javed, A Tariq, D Šamec… - Molecular …, 2017 - Springer
Alzheimer's disease (AD) is the leading cause of dementia in the elderly and is
characterized by progressive cognitive and memory deficits. The pathological hallmarks of …

Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer's disease

C Lu, Y Guo, J Yan, Z Luo, HB Luo, M Yan… - Journal of Medicinal …, 2013 - ACS Publications
A series of multitarget-directed resveratrol derivatives was designed and synthesized for the
treatment of Alzheimer's disease (AD). In vitro studies indicated that most of the target …

Protein folding and aggregation into amyloid: the interference by natural phenolic compounds

M Stefani, S Rigacci - International journal of molecular sciences, 2013 - mdpi.com
Amyloid aggregation is a hallmark of several degenerative diseases affecting the brain or
peripheral tissues, whose intermediates (oligomers, protofibrils) and final mature fibrils …